Cyclosporine vs Nivolumab
Cyclosporine vs Nivolumab: Overview
This comparison examines the pharmacological differences between Cyclosporine and Nivolumab.
Mechanism of Action
Cyclosporine: Calcineurin inhibitor suppressing T-cell activation.
Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.
Pharmacokinetics
Half-life: Cyclosporine β 6-12 hours; Nivolumab β 27 days.
Chemical Properties
Molecular Formula: Cyclosporine β C62H111N11O12.
Molecular Weight: Cyclosporine β 1202.6100 g/mol.
Type: Cyclosporine β Protein; Nivolumab β Antibody.